Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Metastatic Oral Cavity Carcinoma: early-phase trial registry

1 of 1 indexed Metastatic Oral Cavity Carcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Metastatic Oral Cavity Carcinoma: 1 US clinical trial tracked, 1 recruiting.

Metastatic Oral Cavity Carcinoma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 1 of these trials.

Enrollment posture brief

Registry condition metastatic-oral-cavity-carcinoma

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Metastatic Oral Cavity C (this)Metastatic Oral Cavity C (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Metastatic Oral Cavity Carcinoma

Metastatic Oral Cavity Carcinoma lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Metastatic Oral Cavity Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Metastatic Oral Cavity Carcinoma is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Mayo Clinic 1 trials

Named interventions

Most-linked intervention names on Metastatic Oral Cavity Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Erlotinib Hydrochloride Drug
1 trials
Methotrexate Drug
1 trials
Interview Other
1 trials
Imaging Procedure Procedure
1 trials
Celecoxib Drug
1 trials

US sites by state

Facility locations filed on Metastatic Oral Cavity Carcinoma trials. A trial with sites in several states counts in each.

Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Metastatic Oral Cavity Carcinoma page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Metastatic Oral Cavity Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Metastatic Oral Cavity Carcinoma trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metastatic Oral Cavity Carcinoma condition card totals 1 registered trials; most-linked intervention Erlotinib Hydrochloride; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.